DE1936064A1 - Einschlussverbindungen aus pharmtazeutisch aktiven organischen Nitraten und Gallensaeuren - Google Patents
Einschlussverbindungen aus pharmtazeutisch aktiven organischen Nitraten und GallensaeurenInfo
- Publication number
- DE1936064A1 DE1936064A1 DE19691936064 DE1936064A DE1936064A1 DE 1936064 A1 DE1936064 A1 DE 1936064A1 DE 19691936064 DE19691936064 DE 19691936064 DE 1936064 A DE1936064 A DE 1936064A DE 1936064 A1 DE1936064 A1 DE 1936064A1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- bile acid
- organic nitrate
- tetranitrate
- nitrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
- C07C203/02—Esters of nitric acid
- C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE737438 | 1969-08-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1936064A1 true DE1936064A1 (de) | 1971-01-28 |
Family
ID=3855190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691936064 Pending DE1936064A1 (de) | 1969-08-13 | 1969-07-16 | Einschlussverbindungen aus pharmtazeutisch aktiven organischen Nitraten und Gallensaeuren |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US3481955A (https=) |
| BE (1) | BE737438A (https=) |
| DE (1) | DE1936064A1 (https=) |
| NL (1) | NL6911533A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3860712A (en) * | 1973-04-16 | 1975-01-14 | Sterling Drug Inc | Composition and method for treatment of acne or seborrhea |
-
1967
- 1967-10-10 US US674116A patent/US3481955A/en not_active Expired - Lifetime
-
1969
- 1969-07-16 DE DE19691936064 patent/DE1936064A1/de active Pending
- 1969-07-28 NL NL6911533A patent/NL6911533A/xx unknown
- 1969-08-13 BE BE737438D patent/BE737438A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3481955A (en) | 1969-12-02 |
| BE737438A (https=) | 1970-02-13 |
| NL6911533A (https=) | 1971-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69321596T2 (de) | Ester und kombinationen von einem organischen nitrat und einem salicyclat | |
| DE2822882C2 (https=) | ||
| DE3144183C2 (https=) | ||
| DE602004011790T2 (de) | Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung | |
| DE3042332C2 (https=) | ||
| DD235450B1 (de) | Verfahren zur herstellung neuer 1-(2-hydroxyaryl)-alkan-1-on-oxime | |
| DE29924789U1 (de) | Neue Kristallmodifikation N von Torasemid | |
| DE3038966C2 (https=) | ||
| EP0029247A1 (de) | Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE1936064A1 (de) | Einschlussverbindungen aus pharmtazeutisch aktiven organischen Nitraten und Gallensaeuren | |
| DE2621507A1 (de) | Cardenolid-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2844993A1 (de) | N-benzyl-anthracyclinverbindungen und diese enthaltende arzneimittel | |
| DE3814856C2 (https=) | ||
| DE2104179C3 (de) | exo-2-Phenyl-bicyclo- [2,2,1] -heptan-2- (N-methylpiperidol-4)-carbonsäureester und dessen Salze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2829619A1 (de) | Arzneimittel, enthaltend benzyliden- 2-benzofurane | |
| DE2324993C3 (de) | 4'-dehydro-oleandrin, verfahren zu dessen herstellung sowie ein diese verbindung enthaltendes pharmazeutisches praeparat | |
| DE2004301A1 (de) | Phenylserinderivate | |
| DE2839311C2 (de) | Pharmazeutisches Präparat gegen Geschwüre | |
| DE2131946A1 (de) | Salze der Orotsaeure mit Aminoalkoholen sowie Verfahren zu deren Herstellung und Anwendung | |
| DE2307795C3 (de) | 11 beta 17alpha, 21 Trihydroxy-6 | |
| DE2461494A1 (de) | 2-amino-2-thiazolin und pharmakologisch wirksame saeuren | |
| AT326684B (de) | Verfahren zur herstellung von neuen substituierten n-carbamcylcxyphenylcarbamaten | |
| DE2733056A1 (de) | Vincamenin und seine saeureadditionssalze, quaternaeren vincameniniumsalze und molekuelverbindungen, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben | |
| DE4017766A1 (de) | Neue saponine | |
| AT222805B (de) | Verfahren zur Herstellung eines neuen Derivates des Antibiotikums Kanamycin |